Researcher
Yana Debie
- Keywords (University of Antwerp):Medicine
- Disciplines (University of Antwerp):Adaptive immunology, Cancer therapy
Affiliations
- Virology (Research unit)
Member
From6 Dec 2021 → 30 Jun 2022 - Center for Oncological Research (CORE) (Research group)
Member
From1 Oct 2021 → Today
Projects
1 - 1 of 1
- Investigation to reveal the immune reaction upon COVID vaccination in the Belgian cancer population: COVID protection and vaccine safety (REAL-V).From1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
Publications
1 - 6 of 6
- Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with cancer(2023)
Authors: Yana Debie, Jonas Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Greetje Vanhoutte, Elly Marcq, Lisa Verheggen, Debbie Le Blon, Maria Goossens, et al.
Pages: 635 - 646 - Boosting capacity of a fourth dose BNT162b2 in cancer patients(2023)
Authors: Yana Debie, Peter Van Dam, Maria Goossens, Marc Peeters, Timon Vandamme
Pages: 121 - 123 - Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors(2022)
Authors: Angelina Konnova, Fien De Winter, Akshita Gupta, An Hotterbeekx, Matilda Berkell, Laure-Anne Teuwen, Greetje Vanhoutte, Silke Raats, Isolde Van der Massen, Yana Debie, et al.
Pages: 1 - 10 - Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients(2022)
Authors: Peter Van Dam, Yana Debie, Laure-Anne Teuwen, L. Verbruggen, Greetje Vanhoutte, Lieselot Croes, Christof Vulsteke, Sébastien Anguille, Timon Vandamme, Marc Peeters
Pages: 1 - 2 - Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in cancer patients(2022)
Authors: Yana Debie, Timon Vandamme, Maria E. Goossens, Peter Van Dam, Marc Peeters
Pages: 177 - 179 - Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment(2021)
Authors: Marc Peeters, L. Verbruggen, Laure-Anne Teuwen, Greetje Vanhoutte, S. Vande Kerckhove, Sanne Raats, I. Van der Massen, Yana Debie, M. Huizing, P. Pannus, et al.